The study for detecting EGFR and K-ras mutation in plasma of patinets with cancer

The study for detecting EGFR and K-ras mutation in plasma of patinets with cancer - The study for detecting EGFR and K-ras mutation in plasma of patinets with cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012460

Enrollment

100

Registered

2013-12-02

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

blood examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with cancer other than lung cancer Patients without curative treatment Patients without any other cancer Patients with written informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Frequency of EGFR and K-ras mutation in plasma of patients with cancer	—

Secondary

Measure	Time frame
False positive rate of EGFR in plasma Concordance rate of K-ras mutation between tissue and plasma	—

Countries

Japan

Contacts

Public ContactToshinari Yagi

Osaka Medical Center for Cancer and Cardiovascular diseases Clinical Oncology

yagi-to@mc.pref.osaka.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026